BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 31790762)

  • 1. SPIN1 triggers abnormal lipid metabolism and enhances tumor growth in liver cancer.
    Zhao M; Bu Y; Feng J; Zhang H; Chen Y; Yang G; Liu Z; Yuan H; Yuan Y; Liu L; Yun H; Wang J; Zhang X
    Cancer Lett; 2020 Feb; 470():54-63. PubMed ID: 31790762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ZHX2 inhibits SREBP1c-mediated de novo lipogenesis in hepatocellular carcinoma via miR-24-3p.
    Yu X; Lin Q; Wu Z; Zhang Y; Wang T; Zhao S; Song X; Chen C; Wang Z; Xu L; Li C; Gao L; Liang X; Yue X; Ma C
    J Pathol; 2020 Dec; 252(4):358-370. PubMed ID: 32770671
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD147 reprograms fatty acid metabolism in hepatocellular carcinoma cells through Akt/mTOR/SREBP1c and P38/PPARα pathways.
    Li J; Huang Q; Long X; Zhang J; Huang X; Aa J; Yang H; Chen Z; Xing J
    J Hepatol; 2015 Dec; 63(6):1378-89. PubMed ID: 26282231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. E2F1-activated SPIN1 promotes tumor growth via a MDM2-p21-E2F1 feedback loop in gastric cancer.
    Lv BB; Ma RR; Chen X; Zhang GH; Song L; Wang SX; Wang YW; Liu HT; Gao P
    Mol Oncol; 2020 Oct; 14(10):2629-2645. PubMed ID: 32767629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pivotal Role of Fatty Acid Synthase in c-MYC Driven Hepatocarcinogenesis.
    Jia J; Che L; Cigliano A; Wang X; Peitta G; Tao J; Zhong S; Ribback S; Evert M; Chen X; Calvisi DF
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33187130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-489 inhibits proliferation, cell cycle progression and induces apoptosis of glioma cells via targeting SPIN1-mediated PI3K/AKT pathway.
    Li Y; Ma X; Wang Y; Li G
    Biomed Pharmacother; 2017 Sep; 93():435-443. PubMed ID: 28666210
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SPIN1 promotes tumorigenesis by blocking the uL18 (universal large ribosomal subunit protein 18)-MDM2-p53 pathway in human cancer.
    Fang Z; Cao B; Liao JM; Deng J; Plummer KD; Liao P; Liu T; Zhang W; Zhang K; Li L; Margolin D; Zeng SX; Xiong J; Lu H
    Elife; 2018 Mar; 7():. PubMed ID: 29547122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spindlin 1 is essential for metaphase II stage maintenance and chromosomal stability in porcine oocytes.
    Choi JW; Zhao MH; Liang S; Guo J; Lin ZL; Li YH; Jo YJ; Kim NH; Cui XS
    Mol Hum Reprod; 2017 Mar; 23(3):166-176. PubMed ID: 28364522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway.
    Chen J; Ding C; Chen Y; Hu W; Yu C; Peng C; Feng X; Cheng Q; Wu W; Lu Y; Xie H; Zhou L; Wu J; Zheng S
    Cancer Lett; 2021 Apr; 502():154-165. PubMed ID: 33340617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cholesterol biosynthesis supports the growth of hepatocarcinoma lesions depleted of fatty acid synthase in mice and humans.
    Che L; Chi W; Qiao Y; Zhang J; Song X; Liu Y; Li L; Jia J; Pilo MG; Wang J; Cigliano A; Ma Z; Kuang W; Tang Z; Zhang Z; Shui G; Ribback S; Dombrowski F; Evert M; Pascale RM; Cossu C; Pes GM; Osborne TF; Calvisi DF; Chen X; Chen L
    Gut; 2020 Jan; 69(1):177-186. PubMed ID: 30954949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma.
    Li T; Weng J; Zhang Y; Liang K; Fu G; Li Y; Bai X; Gao Y
    Cell Death Dis; 2019 Aug; 10(8):619. PubMed ID: 31409773
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of hepatoma-derived growth factor in promoting de novo lipogenesis and tumorigenesis in hepatocellular carcinoma.
    Min X; Wen J; Zhao L; Wang K; Li Q; Huang G; Liu J; Zhao X
    Mol Oncol; 2018 Sep; 12(9):1480-1497. PubMed ID: 30004626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZNF143-Mediated H3K9 Trimethylation Upregulates CDC6 by Activating MDIG in Hepatocellular Carcinoma.
    Zhang L; Huo Q; Ge C; Zhao F; Zhou Q; Chen X; Tian H; Chen T; Xie H; Cui Y; Yao M; Li H; Li J
    Cancer Res; 2020 Jun; 80(12):2599-2611. PubMed ID: 32312832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of SPIN1-mediated PI3K-Akt pathway by miR-489 increases chemosensitivity in breast cancer.
    Chen X; Wang YW; Xing AY; Xiang S; Shi DB; Liu L; Li YX; Gao P
    J Pathol; 2016 Aug; 239(4):459-72. PubMed ID: 27171498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inactivation of fatty acid synthase impairs hepatocarcinogenesis driven by AKT in mice and humans.
    Li L; Pilo GM; Li X; Cigliano A; Latte G; Che L; Joseph C; Mela M; Wang C; Jiang L; Ribback S; Simile MM; Pascale RM; Dombrowski F; Evert M; Semenkovich CF; Chen X; Calvisi DF
    J Hepatol; 2016 Feb; 64(2):333-341. PubMed ID: 26476289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-21 is a potential link between non-alcoholic fatty liver disease and hepatocellular carcinoma via modulation of the HBP1-p53-Srebp1c pathway.
    Wu H; Ng R; Chen X; Steer CJ; Song G
    Gut; 2016 Nov; 65(11):1850-1860. PubMed ID: 26282675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone code reader SPIN1 controls RET signaling in liposarcoma.
    Franz H; Greschik H; Willmann D; Ozretić L; Jilg CA; Wardelmann E; Jung M; Buettner R; Schüle R
    Oncotarget; 2015 Mar; 6(7):4773-89. PubMed ID: 25749382
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spindlin1 alters the metaphase to anaphase transition in meiosis I through regulation of BUB3 expression in porcine oocytes.
    Choi JW; Zhou W; Nie ZW; Niu YJ; Shin KT; Cui XS
    J Cell Physiol; 2019 Jun; 234(6):8963-8974. PubMed ID: 30317618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SPIN1, negatively regulated by miR-148/152, enhances Adriamycin resistance via upregulating drug metabolizing enzymes and transporter in breast cancer.
    Chen X; Wang YW; Gao P
    J Exp Clin Cancer Res; 2018 May; 37(1):100. PubMed ID: 29743122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer.
    Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L
    Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.